| PMID | Title | Display |
|---|
| 10021420 | High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. |    |
|
| 10071955 | Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity. | |
|
| 10231662 | Inhibition of nitric oxide synthesis in wounds: pharmacology and effect on accumulation of collagen in wounds in mice. | |
|
| 10425590 | Clostridial collagenase releases bioactive fragments from extracellular matrix molecules. | |
|
| 10501915 | Antiangiogenic potential of camptothecin and topotecan. | |
|
| 10502292 | Promoter competitors as novel antifibrotics that inhibit transforming growth factor-beta induction of collagen and noncollagen protein synthesis in fibroblasts. | |
|
| 10657429 | Growth factors stimulate neointimal cells in vitro and increase the thickness of the neointima formed at the neck of porcine aneurysms treated by embolization. | |
|
| 10659843 | Biomimetic synthesis of ordered silica structures mediated by block copolypeptides. | |
|
| 10679822 | A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. | |
|
| 10683192 | Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. | |
|
